Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The effectiveness of NIV is clearly demonstrated but no recent studies describe the prescription based on clinical data and the conditions of using NIV at home according the various respiratory diseases.
The investigators' purpose is that a better knowledge of NIV practices could improve both the quality to support patients at home and the efficacy of the treatment.
The main objective of this study is to analyze the clinical data justifying the prescription of NIV advice according respiratory disease. The secondary objectives are to study comorbidities, treatment failures, survival rate during the study period.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Non-invasive ventilation | Device | Home NIV installation |
| Measure | Description | Time Frame |
|---|---|---|
| Clinical data leading to NIV device prescription | Age, blood gases, BMI, etiology, pulmonary function,comorbidities | Day 1 |
| Measure | Description | Time Frame |
|---|---|---|
| Change in blood gases | 4 months, 1 year and 2 years after inclusion | |
| Change in the possible comorbidities | 4 months, 1 year and 2 years after inclusion | |
| Treatment compliance |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Patients with respiratoy insufficiency
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Didier FORET | Contact | 33 (1) 56 81 40 60 | antadir@antadir.com |
| Name | Affiliation | Role |
|---|---|---|
| Claudio RABEC, MD | Centre Hospitalier Universitaire Dijon | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| CHU d'Angers | Not yet recruiting | Angers | France |
Not provided
Not provided
Not provided
Not provided
| Initiation of treatment to 4 months |
| Treatment compliance | 4 months to 1 year |
| Treatment compliance | 1 year to 2 years (end of study) |
| Hospitalizations | During the study period all hospitalizations will be notify | 4 months |
| Hospitalizations | During the study period all hospitalizations will be notify | 1 year |
| Hospitalizations | During the study period all hospitalizations will be notify | 2 years |
| Survival rate | 4 months |
| Survival rate | 1 year |
| Survival rate | 2 years |
| CHU de Besançon | Not yet recruiting | Besançon | France |
|
| CH de Cannes | Not yet recruiting | Cannes | France |
|
| CHU de Dijon | Recruiting | Dijon | France |
|
| Garches | Not yet recruiting | Garches | France |
|
| CHU de Grenoble | Not yet recruiting | Grenoble | France |
|
| CHD de la Réunion | Not yet recruiting | La Réunion | France |
|
| CHU de Lille | Not yet recruiting | Lille | France |
|
| CHU de Limoges | Not yet recruiting | Limoges | France |
|
| CHU de Nancy | Not yet recruiting | Nancy | France |
|
| AP-HP Pitié-Salpêtrière | Not yet recruiting | Paris | France |
|
| Hôpital Edouard Rist | Not yet recruiting | Paris | France |
|
| CHU de Rouen | Recruiting | Rouen | France |
|
| CHU de Rouen | Not yet recruiting | Rouen | France |
|
| CHU de Strasbourg | Not yet recruiting | Strasbourg | France |
|
| CHU de Toulouse | Not yet recruiting | Toulouse | France |
|
| Hôpital Robert Schuman | Not yet recruiting | Vantoux | France |
|
| ID | Term |
|---|---|
| D012131 | Respiratory Insufficiency |
| ID | Term |
|---|---|
| D012120 | Respiration Disorders |
| D012140 | Respiratory Tract Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D063087 | Noninvasive Ventilation |
| ID | Term |
|---|---|
| D012121 | Respiration, Artificial |
| D058109 | Airway Management |
| D013812 | Therapeutics |
| D012138 | Respiratory Therapy |
Not provided
Not provided